文献速递肺结节与肺癌

球囊扩张辅助支气管镜送达:外周肺野取材新技术的首次人体试验

Balloon dilatation for bronchoscope delivery: first-in-human trial of a novel technique for peripheral lung field access.
PubMed 文献 · Thorax · 2025-12-15

这项多中心单臂前瞻性研究纳入22例支气管征阳性且病灶<20mm的患者,采用球囊扩张支气管镜送达(BDBD)技术辅助经支气管活检。18例最终确诊癌症者中,BDBD均成功推进支气管镜且无严重并发症,17例可直接看到活检部位,14例检出癌症,诊断敏感度为77.8%(14/18)。平均推进2.3个分叉,提示该技术有望提高小外周肺病灶的诊断敏感度。

要点

  • BDBD在18例癌症患者中均成功推进支气管镜,无严重并发症。
  • 对<20mm支气管征阳性病灶,恶性诊断敏感度为77.8%(14/18)。
  • BDBD平均可推进2.3个分叉,17例可直接看到活检部位。

核心结论

  • 在这项小样本观察性研究中,BDBD似为提高小外周肺病灶支气管镜诊断敏感度的有前景技术,仍需大队列验证。

研究设计与样本

  • 多中心、单臂、前瞻性研究,纳入支气管征阳性且病灶<20mm的患者。
  • 在清醒镇静下使用超细或细支气管镜,无法推进时采用BDBD技术接近目标后活检。
  • 主要终点为特定操作流程所取标本的恶性诊断敏感度,流程定义为球囊扩张推进支气管镜、直接看到活检部位且无严重不良事件。

主要发现

  • 22例接受BDBD支气管镜检查的患者中,18例最终确诊癌症。
  • BDBD在全部18例中成功推进支气管镜且无严重并发症,17例可直接看到活检部位,14例检出癌症。
  • 恶性诊断敏感度为77.8%(14/18)。
  • 另有1例符合全部操作标准者确诊隐球菌病,1例未直接看到活检部位者确诊癌症。
  • BDBD平均使支气管镜推进2.3个分叉。

关键数值与推荐

  • 纳入标准为支气管征阳性且病灶<20mm。
  • 主要终点恶性诊断敏感度为77.8%(14/18)。
  • BDBD平均推进2.3个分叉。

临床怎么用

  • 对支气管征阳性的小外周肺病灶,常规支气管镜无法推进时可考虑BDBD辅助接近目标后活检。
  • 操作中应争取直接看到活检部位,并在无严重不良事件前提下完成取材。

局限性

  • 研究为小样本单臂观察性设计。
  • 结论需在更大队列中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bronchoscopic limitations in reaching peripheral pulmonary lesions (PPLs) can compromise biopsy sensitivity, especially for small PPLs. Therefore, we developed the balloon dilatation for bronchoscope delivery (BDBD) technique to dilate bronchial pathways and facilitate bronchoscope advancement into the periphery. This study evaluated the diagnostic performance and safety profile of transbronchial biopsy using this technique. METHODS: This multicentre, single-arm, prospective study included patients with bronchus sign-positive PPLs measuring <20 mm. Bronchoscopy was performed using ultrathin or thin bronchoscopes under conscious sedation. When the bronchoscope could not advance further, the BDBD technique was used to approach closer to the target, followed by biopsies. The primary endpoint was the diagnostic sensitivity for malignancy in specimens obtained through the specified procedure, defined as bronchoscope advancement using balloon dilatation, direct biopsy site visualisation and absence of serious adverse events. RESULTS: Eighteen of 22 patients who underwent bronchoscopy with the BDBD technique were ultimately diagnosed with cancer. BDBD enabled bronchoscope advancement in all 18 cases without serious complications, allowed direct biopsy site visualisation in 17 and detected cancer in 14. Thus, the diagnostic sensitivity for malignancy was 77.8% (14/18). Beyond these cases, one patient who met all procedural criteria was diagnosed with cryptococcosis. Another patient was diagnosed with cancer without direct visualisation. On average, BDBD enabled bronchoscope advancement by 2.3 bifurcations. CONCLUSION: In this small observational study, BDBD appeared to be a promising technique for improving the diagnostic sensitivity of bronchoscopy for small PPLs. Further validation is necessary in large cohorts. TRIAL REGISTRATION NUMBER: jRCT2052220174.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Miyake K, Oki M, Suzuki H, et al. Balloon dilatation for bronchoscope delivery: first-in-human trial of a novel technique for peripheral lung field access. Thorax. 2025. PMID: 41249019. doi:10.1136/thorax-2025-223218

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。